Dr. Elizabeth A. Brém is a triple-board certified UCI Health hematologist-oncologist and medical oncologist who specializes in the diagnosis and treatment of lymphoma and other hematologic malignancies. She earned her medical degree magna cum laude from the University at Buffalo Jacobs School of Medicine and Biomedical Sciences in Buffalo, N.Y. She then completed an internal medicine residency and a hematology-oncology fellowship at Beth Israel Deaconess Medical Center in Boston, where she was a clinical fellow at Harvard Medical School. In Boston, she also did research training at the Dana Farber Cancer Institute in the lab of Dr. Anthony Letai, studying the Bcl-2 family of proteins and its role as a therapeutic target and source of therapy resistance in lymphomas. Her research focus is on lymphoma and BCL-2 family proteins in the regulation of apoptosis, or normal cell death. She is an active member of the American Society of Hematology, a member of the Southwest Oncology Group's Lymphoma Working Group and the University of California Hematologic Malignancies Consortium. Her goal is to help design and conduct innovative clinical trials for patients with lymphoma.
Partial Data by Infogroup (c) 2024. All rights reserved.
